724 related articles for article (PubMed ID: 32759302)
21. Gut microbiome in modulating immune checkpoint inhibitors.
Li X; Zhang S; Guo G; Han J; Yu J
EBioMedicine; 2022 Aug; 82():104163. PubMed ID: 35841869
[TBL] [Abstract][Full Text] [Related]
22. The gut microbiota in type 1 diabetes: friend or foe?
Gavin PG; Hamilton-Williams EE
Curr Opin Endocrinol Diabetes Obes; 2019 Aug; 26(4):207-212. PubMed ID: 31145129
[TBL] [Abstract][Full Text] [Related]
23. The emerging role of the gut microbiome in cancer cell plasticity and therapeutic resistance.
Mondal P; Meeran SM
Cancer Metastasis Rev; 2024 Mar; 43(1):135-154. PubMed ID: 37707749
[TBL] [Abstract][Full Text] [Related]
24. The role of the microbiome in drug resistance in gastrointestinal cancers.
Garajová I; Balsano R; Wang H; Leonardi F; Giovannetti E; Deng D; Peters GJ
Expert Rev Anticancer Ther; 2021 Feb; 21(2):165-176. PubMed ID: 33115280
[No Abstract] [Full Text] [Related]
25. Novel insights on gut microbiota manipulation and immune checkpoint inhibition in cancer (Review).
Vivarelli S; Falzone L; Leonardi GC; Salmeri M; Libra M
Int J Oncol; 2021 Sep; 59(3):. PubMed ID: 34396439
[TBL] [Abstract][Full Text] [Related]
26. The gut microbiota can be a potential regulator and treatment target of bone metastasis.
Contino KF; Yadav H; Shiozawa Y
Biochem Pharmacol; 2022 Mar; 197():114916. PubMed ID: 35041811
[TBL] [Abstract][Full Text] [Related]
27. Auxiliary antitumor effects of fungal proteins from Hericium erinaceus by target on the gut microbiota.
Wang D; Zhu X; Tang X; Li H; Yizhen X; Chen D
J Food Sci; 2020 Jun; 85(6):1872-1890. PubMed ID: 32460371
[TBL] [Abstract][Full Text] [Related]
28. Gut microbiome in gastrointestinal cancer: a friend or foe?
Liu Y; Baba Y; Ishimoto T; Gu X; Zhang J; Nomoto D; Okadome K; Baba H; Qiu P
Int J Biol Sci; 2022; 18(10):4101-4117. PubMed ID: 35844804
[TBL] [Abstract][Full Text] [Related]
29. [Gut microbiota and efficacy of cancer therapies].
Vétizou M; Daillère R; Zitvogel L
Biol Aujourdhui; 2017; 211(1):51-67. PubMed ID: 28682227
[TBL] [Abstract][Full Text] [Related]
30. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.
Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X
Digestion; 2019; 100(1):72-78. PubMed ID: 30332668
[TBL] [Abstract][Full Text] [Related]
31. Tumor-Associated Microbiome: Where Do We Stand?
Oliva M; Mulet-Margalef N; Ochoa-De-Olza M; Napoli S; Mas J; Laquente B; Alemany L; Duell EJ; Nuciforo P; Moreno V
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535583
[TBL] [Abstract][Full Text] [Related]
32. Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs - is it a new perspective for personalized treatment of cancer patients?
Kaźmierczak-Siedlecka K; Bulman N; Ulasiński P; Sobocki BK; Połom K; Marano L; Kalinowski L; Skonieczna-Żydecka K
Gut Microbes; 2023 Dec; 15(2):2281017. PubMed ID: 37985748
[TBL] [Abstract][Full Text] [Related]
33. The impact of modulating the gastrointestinal microbiota in cancer patients.
Morkūnas E; Skiecevičienė J; Kupčinskas J
Best Pract Res Clin Gastroenterol; 2020; 48-49():101700. PubMed ID: 33317795
[TBL] [Abstract][Full Text] [Related]
34. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
35. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer.
Yuan L; Zhang S; Li H; Yang F; Mushtaq N; Ullah S; Shi Y; An C; Xu J
Biomed Pharmacother; 2018 Dec; 108():184-193. PubMed ID: 30219675
[TBL] [Abstract][Full Text] [Related]
36. Our Little Friends with Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders.
Ejtahed HS; Angoorani P; Soroush AR; Siadat SD; Shirzad N; Hasani-Ranjbar S; Larijani B
Endocr Metab Immune Disord Drug Targets; 2020; 20(3):344-350. PubMed ID: 31566142
[TBL] [Abstract][Full Text] [Related]
37. The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?
Roberto M; Carconi C; Cerreti M; Schipilliti FM; Botticelli A; Mazzuca F; Marchetti P
Front Immunol; 2021; 12():704942. PubMed ID: 34489956
[TBL] [Abstract][Full Text] [Related]
38. Gut microbiota modulation of chemotherapy efficacy and toxicity.
Alexander JL; Wilson ID; Teare J; Marchesi JR; Nicholson JK; Kinross JM
Nat Rev Gastroenterol Hepatol; 2017 Jun; 14(6):356-365. PubMed ID: 28270698
[TBL] [Abstract][Full Text] [Related]
39. Intestinal microbiota: A potential target for enhancing the antitumor efficacy and reducing the toxicity of immune checkpoint inhibitors.
Luo B; Zhang Y; Zhang C; Liu X; Shi C
Cancer Lett; 2021 Jul; 509():53-62. PubMed ID: 33845122
[TBL] [Abstract][Full Text] [Related]
40. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications.
Zhao LY; Mei JX; Yu G; Lei L; Zhang WH; Liu K; Chen XL; Kołat D; Yang K; Hu JK
Signal Transduct Target Ther; 2023 May; 8(1):201. PubMed ID: 37179402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
